how to recover anti cancer

Tagrisso 80mg A Tagrisso 80mg tablet is containing an active substance known as osimertinib , which is formerly known as Mereletinib. Tagrisso 80mg is considered as third generation medicine, which is available in tablet form. Tagrisso 80mg tablet  is an inevitable, selectively deviated epidermal growth factor receptor prohibitor, containing anti-cancer activity. The pharmacological category of Tagrisso 40mg is tyrosine kinase prohibitor. INDICATION A Tagrisso 80mg tablet is widely indicated as first line therapy for advanced non-small cell lung cancer with EGFR mutation positive patients. Tagrisso 40mg is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment. Tagrisso 80mg, Tagrisso 80mg tablet DOSAGE The usual prescribed dosage of Tagrisso tablets are, 80mg tablet should be taken as a single dose . Tagrisso 80mg tablet should be administ

Tagrisso 40mg A Tagrisso 40 mg tablet is containing an active substance known as Osimeritinib , which is formerly known as Mereletinib. Tagrisso 40mg  is considered as third generation medicine, which is available in tablet form. Tagrisso 40 mg is an inevitable, selectively deviated epidermal growth factor receptor prohibitor, containing anti-cancer activity. The pharmacological category of Tagrisso 40mg tablet is tyrosine kinase prohibitor. INDICATION A Tagrisso 40mg (osimertinib) tablet is widely indicated as first line therapy for advanced non-small cell lung cancer with EGFR mutation positive patients. Tagrisso 40mg tablet is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment. Tagrisso 40mg, Tagrisso 40mg tablet DOSAGE The usual prescribed dosage of Tagrisso tablets are, 80mg tablet should be taken as a single dose . Tagrisso 40mg ta

Sutent 50mg Sutent 50mg  is an antineoplastic drug which prevents the growth and spread of cancer cells in the body. Sutent 50mg tablet belongs to targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It prohibits the actions of vascular endothelial growth factor (VEGF) and is an angiogenesis inhibitor. Sutent 50mg  is a prescription drug which is used under the guidance of medical practitioners sutent 50mg,sutent 50mg tablet INDICATION Sutent 50mg tablet is used for the treatment in patients having Gastrointestinal stromal tumor Sutent 50mg  is used for the treatment in patients having Advanced pancreatic neuroendocrine tumor Sutent 50mg is used for the treatment in patients having Advanced renal cell cancer DOSAGE The recommended dosage for the following condition as follows : Dose after disease progression on or intolerance to imatinib mesylate The usual dose for patients with Gastrointestinal Stromal Tumor is 50 mg PO qDay for 4 weeks, followed by

Sutent 25mg Sutent 25mg is an antineoplastic drug which prevents the growth and spread of cancer cells in the body. Sutent 25mg tablet belongs to targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It prohibits the actions of vascular endothelial growth factor (VEGF) and is an angiogenesis inhibitor. Sutent 25mg tablet is a prescription drug which is used under the guidance of medical practitioners sutent 25mg,sutent 25mg capsule INDICATION Sutent 25mg tablet is used for the treatment in patients having Gastrointestinal stromal tumor Sutent 25mg is used for the treatment in patients having Advanced pancreatic neuroendocrine tumor Sutent 25mg tablet is used for the treatment in patients having Advanced renal cell cancer DOSAGE The recommended dosage for the following condition as follows : Dose after disease progression on or intolerance to imatinib mesylate The usual dose for patients with Gastrointestinal Stromal Tumor is 50 mg PO qDay for 4 we

Lanib 250mg Lanib 250mg tablets are classified as an anti-cancer agent, which is an orally active drug used for treating breast cancer. Chemically classified as quinazoline with strong anti-cancer effect and the tablet Lanib is a synthetic oral tablet Normally targeted therapy or tyrosine kinase inhibitor drugs are capable of increasing the plasma aminotransferase levels which may lead to liver injury. Lanib 250mg tablets are classified as; 1.Tyrosine kinase prohibition 2. Stop the HER2/neu& epidermal growth factor receptor activity 3.Targeted therapy 4.Signal transduction prohibition. INDICATION Primarily Lanib 250mg indicated for advanced breast cancer. Lanib is indicated for the combination with Capecitabine tablets are normally indicated for the treatment of metastatic breast cancer patients in whose cancer cells expressed with EGFR 2 (HER2) and already patients may get an anthracycline, taxane& Trastuzumab. lanip 250mg,lanip 250mg tablet DOSAGE In HER2 posi

Erlonat 100mg Erlonat 100mg tablets consist of active ingredients known as Erlotinib (Generic Tarceva), that is considered as quinazoline derivative and anti-cancer agents that responses as a protein kinase prohibition for EGFR related to tyrosine kinase. Erlonat 100mg is majorly used in the treatment of non-small cell lung cancer and pancreatic carcinoma and also involved to treat various cancers. Erlonat 100mg has especially aimed at the epidermal growth factor receptor tyrosine kinase. Erlonat 100mg,Erlonat 100mg tablet USES OF Erlonat Non-small cell lung cancer: Erlonat 100mg tablet is indicated as continuance therapy, in patients with long-lasting or metastasis non-small cell lung carcinoma, whose disease has not to get advance after four cycles with platinum-based first-line therapy. Erlonat 100mg is used in this condition only after the failure of one prior chemotherapy regimen. No clinical advantages occur while using Erlonat 100mg with platinum-based compounds

Suninat 50mg Suninat 50mg is an antineoplastic drug which prevents the growth and spread of cancer cells in the body. Suninat 50mg capsule belongs to targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It prohibits the actions of vascular endothelial growth factor (VEGF) and is an angiogenesis inhibitor. Suninat 50mg is a prescription drug which is used under the guidance of medical practitioners INDICATION Suninat 50mg  is used for the treatment in patients having Gastrointestinal stromal tumor Suninat 50mg capsule is used for the treatment in patients having Advanced pancreatic neuroendocrine tumor Suninat 50mg capsule is used for the treatment in patients having Advanced renal cell cancer suninat 50mg,suninat 50mg capsule DOSAGE The recommended dosage for the following condition as follows : Dose after disease progression on or intolerance to imatinib mesylate The usual dose for patients with Gastrointestinal Stromal Tumor is 50 mg PO qDay for